U
Cognetivity Neurosciences Ltd.
CGNSF
$0.01
$0.000.00%
E
Sell
9/18/2023Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to E+ from D- on 9/18/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.44 to 0.18, and debt to equity increased from -0.13 to -0.12.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to E+ from D- on 9/18/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 0.44 to 0.18, and debt to equity increased from -0.13 to -0.12.
D
Sell
3/14/2023Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 03/14/2023.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 03/14/2023.
D
Sell
2/23/2023Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index and volatility index.
D
Sell
2/8/2023Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
12/19/2022Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 12/19/2022 due to a major increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.08 to 0.94, and operating cash flow increased 36.02% from -$264 to -$168.9.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 12/19/2022 due to a major increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.08 to 0.94, and operating cash flow increased 36.02% from -$264 to -$168.9.
D
Sell
6/30/2022Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 6/30/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.29 to 0.24.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 6/30/2022 due to a decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.29 to 0.24.
D
Sell
5/5/2022Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 05/05/2022.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 05/05/2022.
D
Sell
4/20/2022Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 4/20/2022 due to a decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0117 to -$0.0674, EBIT declined 435.01% from -$864 to -$4.62M, and the quick ratio declined from 0.61 to 0.11.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 4/20/2022 due to a decline in the growth index, total return index and solvency index. Earnings per share declined from -$0.0117 to -$0.0674, EBIT declined 435.01% from -$864 to -$4.62M, and the quick ratio declined from 0.61 to 0.11.
D
Sell
11/23/2021Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index and valuation index. Operating cash flow declined 43.53% from -$498 to -$714.8, earnings per share declined from -$0.0098 to -$0.0117, and EBIT declined 8.01% from -$799.9 to -$864.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 11/8/2021 due to a decline in the growth index and valuation index. Operating cash flow declined 43.53% from -$498 to -$714.8, earnings per share declined from -$0.0098 to -$0.0117, and EBIT declined 8.01% from -$799.9 to -$864.
D
Sell
11/9/2020Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 11/9/2020 due to a large increase in the total return index and volatility index.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 11/9/2020 due to a large increase in the total return index and volatility index.
D
Sell
9/30/2020Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 9/30/2020 due to a significant decline in the solvency index, growth index and valuation index. EBIT declined 361.38% from -$98.9 to -$456.3, earnings per share declined from -$0.0025 to -$0.0081, and the quick ratio declined from 0.57 to 0.12.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 9/30/2020 due to a significant decline in the solvency index, growth index and valuation index. EBIT declined 361.38% from -$98.9 to -$456.3, earnings per share declined from -$0.0025 to -$0.0081, and the quick ratio declined from 0.57 to 0.12.
D
Sell
6/18/2020Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 6/18/2020 due to an increase in the valuation index and volatility index.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from D- on 6/18/2020 due to an increase in the valuation index and volatility index.
D
Sell
6/3/2020Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 6/3/2020 due to a major decline in the solvency index, valuation index and total return index.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to D- from D on 6/3/2020 due to a major decline in the solvency index, valuation index and total return index.
D
Sell
12/19/2019Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from E+ on 12/19/2019 due to a large increase in the growth index, valuation index and volatility index. Operating cash flow increased 82.37% from -$547.8 to -$96.6, EBIT increased 5.62% from -$574.3 to -$542, and earnings per share increased from -$0.013 to -$0.0124.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D from E+ on 12/19/2019 due to a large increase in the growth index, valuation index and volatility index. Operating cash flow increased 82.37% from -$547.8 to -$96.6, EBIT increased 5.62% from -$574.3 to -$542, and earnings per share increased from -$0.013 to -$0.0124.
E
Sell
10/24/2019Downgrade
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to E+ from D- on 10/24/2019 due to a decline in the total return index, volatility index and valuation index.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to E+ from D- on 10/24/2019 due to a decline in the total return index, volatility index and valuation index.
D
Sell
7/1/2019Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D- from E on 07/01/2019.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to D- from E on 07/01/2019.
E
Sell
4/1/2019Upgraded
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to E from E- on 4/1/2019 due to a large increase in the growth index, efficiency index and total return index. Earnings per share increased from -$0.036 to -$0.0177, net income increased 42.55% from -$1.29M to -$740.7, and EBIT increased 40.61% from -$1.24M to -$735.7.
Cognetivity Neurosciences Ltd. (CGNSF) was upgraded to E from E- on 4/1/2019 due to a large increase in the growth index, efficiency index and total return index. Earnings per share increased from -$0.036 to -$0.0177, net income increased 42.55% from -$1.29M to -$740.7, and EBIT increased 40.61% from -$1.24M to -$735.7.
E
Sell
12/31/2018None
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to E- from U on 12/31/2018.
Cognetivity Neurosciences Ltd. (CGNSF) was downgraded to E- from U on 12/31/2018.
OTC PK
03/07/2025 10:58AM Eastern
Quotes delayed
